SOM 1.25% 39.5¢ somnomed limited

european expansion

  1. 1,784 Posts.
    lightbulb Created with Sketch. 1
    Great announcement...looking forward to the run :)
    Leading anti-snoring and sleep apnea group, Somnomed Limited, announced today it
    has commenced its expansion to Europe as part of the group’s global expansion
    strategy.
    The company has entered into an agreement with the German company Orthosleep to
    become Somnomed’s Central European laboratory and will play a central role in the
    licensing of partners across the continent.
    Orthosleep is one of Germany’s leading dental labs for sleep dentistry and will train
    and supply the licence partners in each country to developed as markets for the unique
    Somnomed’s locally developed anti-snoring device.
    “This is a very important first step in implementing our new global strategy and
    rolling out our business in Europe”, said Dr Peter Neustadt, Executive Chairman of
    Somnomed.
    “Somnomed plans to appoint a license partner in every country in Europe to achieve
    full market coverage before the end of 2008.Europe has a population of more than
    300 million people and is the second most important market in the world.
    see for full story http://www.asx.com.au/asxpdf/20070605/pdf/312slml70td1md.pdf

 
watchlist Created with Sketch. Add SOM (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
-0.005(1.25%)
Mkt cap ! $85.36M
Open High Low Value Volume
40.0¢ 40.0¢ 37.0¢ $20.82K 54.33K

Buyers (Bids)

No. Vol. Price($)
2 29105 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 6350 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
SOM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.